nLIGHT, Inc. Announces Date for Second Quarter 2021 Earnings Release
Get Alerts LASR Hot Sheet
Join SI Premium – FREE
CAMAS, Wash.--(BUSINESS WIRE)-- nLIGHT, Inc. (Nasdaq: LASR) announced that it will release its financial results for the second quarter of 2021 after the financial markets close on Thursday, August 5, 2021. nLIGHT’s second quarter ended on June 30, 2021.
A conference call and simultaneous webcast to discuss the second quarter results will be held on Thursday, August 5 at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). An audio webcast will be available on the investor relations section of the company's web site at http://investors.nlight.net. A replay of the webcast will be available shortly after the conclusion of the call.
Access to the conference call will also be available by dialing 1-833-535-2198 (U.S., toll-free) or +1-412-902-6775 (international and toll), with the conference title: nLIGHT Second Quarter 2021 Earnings.
About nLIGHT
nLIGHT, Inc is a leading provider of high-power semiconductor and fiber lasers for industrial, microfabrication, aerospace and defense applications. Our lasers are changing not only the way things are made but also the things that can be made. Headquartered in Camas, Washington, nLIGHT employs over 1,275 people with operations in the U.S., China and Finland. For more information, please visit www.nlight.net.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210719005118/en/
Joseph Corso
VP, Corporate Development and Investor Relations
nLIGHT, Inc.
(360) 566-4460
[email protected]
Source: nLIGHT, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Best’s Market Segment Report: Underwriting Conditions for UAE Insurers on Track to Improve Amid IFRS 17 Transition
- ImmunityBio Announces Positive Overall Survival Results of Anktiva Combined With Checkpoint Inhibitors in Non-Small Cell Lung Cancer; Meeting Scheduled with FDA to Discuss Registration Path for ANKTIV
- Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!